David M Tellers

Title: The Innovative Contributions of David M Tellers

Introduction

David M Tellers is a notable inventor based in Cranford, NJ (US), recognized for his significant contributions to the field of chemistry. With a total of 2 patents to his name, Tellers has made strides in developing processes that have practical applications in pharmacology.

Latest Patents

Tellers' latest patents include an asymmetric hydrogenation process, which provides a method for preparing chiral cycloalkanoindole DP receptor antagonists with high enantiomeric excess. This innovation is crucial for the synthesis of compounds that can have therapeutic effects. Another significant patent is for the process of preparing 3-chloromethyl-1,2,4-triazolin-5-one. This compound serves as an important intermediate in the synthesis of pharmacologically active compounds. Additionally, Tellers has disclosed novel semicarbazide salts and their preparation, which are also intermediates for the production of 3-chloromethyl-1,2,4-triazolin-5-one.

Career Highlights

David M Tellers is currently employed at Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to focus on innovative solutions that address complex challenges in drug development and synthesis.

Collaborations

Throughout his career, Tellers has collaborated with esteemed colleagues, including Guy R Humphrey and Kevin Seibert. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

David M Tellers exemplifies the spirit of innovation in the field of chemistry through his patents and contributions to pharmacological research. His work continues to impact the development of new therapeutic compounds, showcasing the importance of inventors in advancing science and technology.